Developer of therapeutics based on polyphenols intended to create a range of technologies for the synthetic optimization of polyphenols. The company engages in developing commercially scalable productions in close cooperation with global partners using fermentation, providing customers with effectively optimized polyphenols with a strong emphasis on flavonoids.

Telo Therapeutics operates a biotechnology company intended to develop medicine to reverse cancer cell immortality. The company's medicine specializes in inhibiting cancer cell immortality by undergoing the immortalization process, leaving healthy cells intact, enabling patients to get cured of diseases such as cancer.

Operator of a biotechnology firm intended to extend the human lifespan and healthspan through telomere maintenance. The company is on the verge of a major breakthrough that will give them control of the telomere length, enabling it to help clients reverse the mechanism of aging.

Operator of a regenerative medicine company intended to improve global healthspan by addressing key hallmarks of prevalent chronic diseases. The company develops and commercializes cell therapies and tissue-engineered systems, enabling healthcare professionals to treat heart failure and osteoarthritis conditions.

Operator of a regenerative medicine company intended to focus on developing and commercializing cell-based therapies for incurable diseases. The company offers a combination of research and development for cell-based medicines, clinical development to test their effectiveness, licensing of regenerative medicine technologies to other companies, and management of intellectual property rights, enabling patients to access potential cures for currently untreatable diseases.

Provider of personalized and preventive medicine services intended to translate the rapidly advancing science of aging into healthcare strategies. The company offers a blood-based measure of cellular senescence and immune function and captures fundamental mechanisms of aging, enabling to understand a person's risk of disease initiation, disease progression, treatment response and adverse events.

New science shows we can live longer and healthier lives. But how do we make this a reality? Agemarker.com is dedicated to giving you the knowledge, support, and tools you need for healthier aging through Telomere Science. Please visit our information clearinghouse and our companion community site, coming soon at telomeres.me .

Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies. The company's Imetelstat, an investigational first-in-class telomerase inhibitor, harnesses Nobel Prize-winning science in a treatment that may change the underlying course of these diseases. Geron was established in 1990 and is headquartered in Foster City, California.

Supporting families worldwide in their battle with Dyskeratosis Congenita and related Telomere Biology Disorders who often face multiple complex illnesses such as bone marrow failure, lung fibrosis, cancer, and many other challenges. Our mission is to provide information and support services to families worldwide affected by Dyskeratosis Congenita and Telomere Biology Disorders, to encourage the medical community’s research in finding causes and effective treatments, and to facilitate improved diagnosis by educating medical providers.

TelomEye Pharmaceuticals creates an innovative therapeutic strategy to stop or reduce the progression of several serious ophthalmologic illnesses, particularly those related to aging. They offer a range of treatment options to keep eyesight clear. TelomEye prevents or slows the progression of very common ophthalmologic disorders, thereby minimizing the impact on the lives of a large number of people from all over the world.